Publication | Open Access

A novel ligand-independent peptide inhibitor of TREM-1 suppresses tumor growth in human lung cancer xenografts and prolongs survival of mice with lipopolysaccharide-induced septic shock

Lipopolysaccharide-induced Septic ShockTumor BiologyProlongs SurvivalMedicineImmunologyPharmacologyImmune Checkpoint InhibitorAnti-cancer AgentCancer BiologyLung CancerCancer Research